From: Angiotensin-converting enzyme 2 is reduced in Alzheimer’s disease in association with increasing amyloid-β and tau pathology
Control (n = 59)
AD (n = 90)
Age, years, mean ± SD
78.5 ± 10.1
78.5 ± 9.7
Sex, F/M
22/37
55/35
PM delay, h, mean ± SD)
43.8 ± 36.4
45.2 ± 25.1